Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer

Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer

US Patent 9254299 · Granted Feb 9, 2016

Estimated economic value: $474,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of assessing and treating autism spectrum disorders using human umbilica2025
Hybridoma cell line secreting an ActA monoclonal antibody and use thereof2025
Methods for the treatment of autism spectrum disorders2023
Methods for the treatment of autism spectrum disorders2021
Predictive biomarker for hypoxia-activated prodrug therapy2020
Treatment of cancer using hypoxia activated prodrugs2015
Antagonists of MCP-1 function and methods of use thereof2007
Antagonists of MCP-1 function and methods of use thereof2006
Antagonists of MCP-1 function and methods of use thereof2006
Antagonist of MCP-1 function, and compositions and methods of use thereof2005
Antagonists of MCP-1 function and methods of use thereof2004
Antagonists of MCP-1 function and methods of use thereof2004